NURS 5334 (UTA ACNP) - Quiz 1 ULTRA Study Guide
(Read-Through)
Built from Woo & Wright + Lippincott 8e (Whalen) + all uploaded slides, notes, practice
sets, and lecture transcripts
Updated: January 19, 2026
How this guide is different:
• No fill-in-the-blank sections. This is designed to READ like a high-yield mini-textbook.
• Every topic is written in UTA-style: safety first, then patient-specific PK/PD, then drug selection, then
monitoring/counseling.
• Includes memorization hooks, 'exam triggers', and stepwise logic you can apply to unfamiliar questions.
Note on practice questions and test-bank materials: Your uploaded practice question documents and
question banks were used to identify what your course emphasizes and to shape the high-yield coverage in
this guide. This guide does not reproduce proprietary questions verbatim; instead, it teaches the underlying
concepts, patterns, and safety rules so you can answer any question style.
Best use:
1. First pass: read Sections 1-3 quickly (foundation).
2. Second pass: slow-read the drug lessons (Sections 5-7) and build flashcards from the 'Must memorize'
blocks.
3. Final pass: use the Rapid Review to drill recall, then do practice questions.
Quiz 1 core competency (what your instructor is really testing)
• You can write a safe, legal, unambiguous prescription.
• You can apply PK/PD principles to patient factors (age, kidney, liver, pregnancy, interactions).
• You can choose the best drug class for common conditions in Module 1 and defend it with
mechanism, adverse effects, and monitoring.
,0) Blueprint: Module Outcomes and Student Learning Outcomes (SLO) -> What to
Master
Outcome What mastery looks like Where it is covered
Prescribing basics You can write a complete Rx and prevent common Section 1 + throughout
errors
PK/PD principles You can solve interaction, half-life, and dose- Section 2
response questions
Prescribing across You adjust plans for peds/pregnancy/older adults Section 3-4 + callouts
lifespan and counsel safely
Bone disease drugs You can select and counsel osteoporosis therapies; Section 5
know what to monitor
Urologic drugs You can separate BPH vs OAB vs ED and choose Section 6
safest class
Eye/ear drugs You can map glaucoma classes and recognize Section 7
systemic risks of drops
Exam habit that boosts scores
• Before choosing an answer, say: Indication -> Contraindications -> Interactions -> Monitoring ->
Counseling.
• If two answers are both effective, choose the one with the best safety profile for THAT patient.
,1) Prescribing Basics: Safety, Legal Elements, and Error-Proof Prescription Writing
This section integrates Woo/Wright prescribing chapters, your prescribing basics notes, and the prescription
safety lectures/slides.
1.1 The prescription as a safety document (think: 'could a stranger safely fill this?')
• A prescription is not just a medication order; it is a communication tool across multiple handoffs
(prescriber -> pharmacy -> patient/caregiver).
• Most preventable outpatient errors occur at: drug selection (wrong drug), dose (especially pediatrics),
or instructions (ambiguous sig).
• The safest prescription is the one that is difficult to misread and hard to misinterpret.
1.2 Components of a complete outpatient prescription (what must be present)
Category Required elements High-yield pitfalls
Patient identifiers Name + DOB (or other identifier) + Similar names; wrong chart;
address/phone if required by system verify identity
Date Date written (and sometimes earliest fill date) Backdating or missing dates
Medication Generic name, dose form, strength, route IR vs ER confusion; wrong
salt/formulation
Sig Dose + route + frequency + duration; PRN Missing PRN reason;
indication abbreviations; unclear
intervals
Dispense Total quantity that matches the sig Default quantity does not
match course duration
Refills Number of refills or 0 Leaving blank; accidental
long-term refills
Substitution DAW as needed; otherwise generic substitution DAW increases cost; affects
adherence
Prescriber ID Name/credentials, signature, contact info; state- Missing identifiers in certain
specific requirements systems
Ambiguity killers (write these out)
• Write 'by mouth' instead of 'PO' when possible in patient instructions.
• Write explicit times/intervals when safety matters (for example, every 8 hours).
• Avoid 'as needed' alone. Use 'as needed FOR [symptom]'.
, • Avoid vague tapers. Write a day-by-day taper schedule.
• For liquids, specify mL and include 'use oral syringe' or 'use dosing syringe'.
1.3 Error-prone abbreviations and notation (quiz gold)
Unsafe notation Why it is unsafe Safer alternative
U Looks like 0 or 4 Write 'units'
IU Looks like IV or 10 Write 'units'
.5 mg No leading zero -> misread as 5 mg 0.5 mg
5.0 mg Trailing zero -> misread as 50 mg 5 mg
tsp/Tbsp Household spoons inaccurate mL only
qd/qod Misread as qid daily or every other day
MS, MSO4, MgSO4 Mix-ups between morphine and magnesium Write full drug name
sulfate
1.4 Computerized prescribing (CPOE/EHR): predictable failure points
• Default doses may be adult doses inserted into pediatric charts; never accept defaults for children.
• Sig templates can contain unsafe abbreviations; always edit to safe language.
• Concentrations: EHR might list multiple mg/5 mL options; choose and verify.
• Dispense quantity autopopulates; after editing sig, recalculate quantity manually.
• Auto-reconciliation can duplicate therapy (same class), especially when generics/brands coexist.
Exam trigger: 'The EHR auto-populated...'
• When a question describes an auto-populated order, the correct answer is often to verify
dose/weight/concentration and correct the prescription BEFORE it is sent.
1.5 Core clinical decision rules (how to choose between similar options)
• Efficacy: choose the drug/class that best treats the condition and addresses patient-specific factors.
• Safety: avoid contraindications; avoid additive adverse effects (sedation, hypotension, bleeding, QT).
• Simplicity: fewer daily doses and clearer instructions improve adherence.
• Cost: generics and covered options improve long-term adherence; expensive meds can become 'no
therapy' if unaffordable.
1.6 Monitoring and documentation (SLO 3)
• Monitoring has three layers: (1) efficacy, (2) safety/toxicity, (3) adherence/tolerability.
(Read-Through)
Built from Woo & Wright + Lippincott 8e (Whalen) + all uploaded slides, notes, practice
sets, and lecture transcripts
Updated: January 19, 2026
How this guide is different:
• No fill-in-the-blank sections. This is designed to READ like a high-yield mini-textbook.
• Every topic is written in UTA-style: safety first, then patient-specific PK/PD, then drug selection, then
monitoring/counseling.
• Includes memorization hooks, 'exam triggers', and stepwise logic you can apply to unfamiliar questions.
Note on practice questions and test-bank materials: Your uploaded practice question documents and
question banks were used to identify what your course emphasizes and to shape the high-yield coverage in
this guide. This guide does not reproduce proprietary questions verbatim; instead, it teaches the underlying
concepts, patterns, and safety rules so you can answer any question style.
Best use:
1. First pass: read Sections 1-3 quickly (foundation).
2. Second pass: slow-read the drug lessons (Sections 5-7) and build flashcards from the 'Must memorize'
blocks.
3. Final pass: use the Rapid Review to drill recall, then do practice questions.
Quiz 1 core competency (what your instructor is really testing)
• You can write a safe, legal, unambiguous prescription.
• You can apply PK/PD principles to patient factors (age, kidney, liver, pregnancy, interactions).
• You can choose the best drug class for common conditions in Module 1 and defend it with
mechanism, adverse effects, and monitoring.
,0) Blueprint: Module Outcomes and Student Learning Outcomes (SLO) -> What to
Master
Outcome What mastery looks like Where it is covered
Prescribing basics You can write a complete Rx and prevent common Section 1 + throughout
errors
PK/PD principles You can solve interaction, half-life, and dose- Section 2
response questions
Prescribing across You adjust plans for peds/pregnancy/older adults Section 3-4 + callouts
lifespan and counsel safely
Bone disease drugs You can select and counsel osteoporosis therapies; Section 5
know what to monitor
Urologic drugs You can separate BPH vs OAB vs ED and choose Section 6
safest class
Eye/ear drugs You can map glaucoma classes and recognize Section 7
systemic risks of drops
Exam habit that boosts scores
• Before choosing an answer, say: Indication -> Contraindications -> Interactions -> Monitoring ->
Counseling.
• If two answers are both effective, choose the one with the best safety profile for THAT patient.
,1) Prescribing Basics: Safety, Legal Elements, and Error-Proof Prescription Writing
This section integrates Woo/Wright prescribing chapters, your prescribing basics notes, and the prescription
safety lectures/slides.
1.1 The prescription as a safety document (think: 'could a stranger safely fill this?')
• A prescription is not just a medication order; it is a communication tool across multiple handoffs
(prescriber -> pharmacy -> patient/caregiver).
• Most preventable outpatient errors occur at: drug selection (wrong drug), dose (especially pediatrics),
or instructions (ambiguous sig).
• The safest prescription is the one that is difficult to misread and hard to misinterpret.
1.2 Components of a complete outpatient prescription (what must be present)
Category Required elements High-yield pitfalls
Patient identifiers Name + DOB (or other identifier) + Similar names; wrong chart;
address/phone if required by system verify identity
Date Date written (and sometimes earliest fill date) Backdating or missing dates
Medication Generic name, dose form, strength, route IR vs ER confusion; wrong
salt/formulation
Sig Dose + route + frequency + duration; PRN Missing PRN reason;
indication abbreviations; unclear
intervals
Dispense Total quantity that matches the sig Default quantity does not
match course duration
Refills Number of refills or 0 Leaving blank; accidental
long-term refills
Substitution DAW as needed; otherwise generic substitution DAW increases cost; affects
adherence
Prescriber ID Name/credentials, signature, contact info; state- Missing identifiers in certain
specific requirements systems
Ambiguity killers (write these out)
• Write 'by mouth' instead of 'PO' when possible in patient instructions.
• Write explicit times/intervals when safety matters (for example, every 8 hours).
• Avoid 'as needed' alone. Use 'as needed FOR [symptom]'.
, • Avoid vague tapers. Write a day-by-day taper schedule.
• For liquids, specify mL and include 'use oral syringe' or 'use dosing syringe'.
1.3 Error-prone abbreviations and notation (quiz gold)
Unsafe notation Why it is unsafe Safer alternative
U Looks like 0 or 4 Write 'units'
IU Looks like IV or 10 Write 'units'
.5 mg No leading zero -> misread as 5 mg 0.5 mg
5.0 mg Trailing zero -> misread as 50 mg 5 mg
tsp/Tbsp Household spoons inaccurate mL only
qd/qod Misread as qid daily or every other day
MS, MSO4, MgSO4 Mix-ups between morphine and magnesium Write full drug name
sulfate
1.4 Computerized prescribing (CPOE/EHR): predictable failure points
• Default doses may be adult doses inserted into pediatric charts; never accept defaults for children.
• Sig templates can contain unsafe abbreviations; always edit to safe language.
• Concentrations: EHR might list multiple mg/5 mL options; choose and verify.
• Dispense quantity autopopulates; after editing sig, recalculate quantity manually.
• Auto-reconciliation can duplicate therapy (same class), especially when generics/brands coexist.
Exam trigger: 'The EHR auto-populated...'
• When a question describes an auto-populated order, the correct answer is often to verify
dose/weight/concentration and correct the prescription BEFORE it is sent.
1.5 Core clinical decision rules (how to choose between similar options)
• Efficacy: choose the drug/class that best treats the condition and addresses patient-specific factors.
• Safety: avoid contraindications; avoid additive adverse effects (sedation, hypotension, bleeding, QT).
• Simplicity: fewer daily doses and clearer instructions improve adherence.
• Cost: generics and covered options improve long-term adherence; expensive meds can become 'no
therapy' if unaffordable.
1.6 Monitoring and documentation (SLO 3)
• Monitoring has three layers: (1) efficacy, (2) safety/toxicity, (3) adherence/tolerability.
